Oxford Investment Consultants LLP
VC Fund
Oxford, United Kingdom
Oxford Investment Consultants LLP is a VC fund in Oxford focused on Software and Health Care. xford Investment Consultants LLP ("OIC") advises Thompson Taraz, the Investment Manager of Oxford Technology and Innovations EIS Fund ("OTIF"). OIC is an Appointed Representative of Stoneware Captial LLP, which is authorized and regulated by the Financial Conduct Authority in the United Kingdom.The focus of OIC research ison University of Oxford spin out companies.Over the last fifteen years Oxford has produced a string of world-class spin-out companies. It is our belief that the next generation of world-class Oxford businesses is just waiting to be discovered.
- Total investments:
- 29
- Last investment:
- Lead investor:
- 17%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Oxford Investment Consultants LLP invests in
Stages Oxford Investment Consultants LLP invests in
Countries Oxford Investment Consultants LLP invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $982k–$12M
- Series A
- $6.3M–$33M
Investment Focus
Industry
- Software 6 (21%)
- Health Care 6 (21%)
- Biotechnology 6 (21%)
- Medical 4 (14%)
- Medical Device 4 (14%)
Stage
- Series A 9 (31%)
- Seed 6 (21%)
- Funding Round 4 (14%)
- Series B 3 (10%)
- Venture - Series Unknown 2 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
George Robinson
Founder
|
Founder | Total investments: 2 | Find email | |
Hector Edwards
Investment Associate
|
Investment Associate | Total investments: 1 | Find email | |
James Mallinson
Partner
|
Partner | Total investments: 1 | Find email | |
Ross Hyett
Founder
|
Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Panda Surgical is a medical equipment manufacturing company that offers surgical instruments accompanied by AI-powered software. | $1.3M / Seed / Oct 05, 2025 | ||
| Diffblue is changing the way software is developed using Artificial Intelligence (AI).Diffblue Cover, the company’s first product, automatically generates tests for Java code to enable development teams to deliver higher quality software, faster. Diffblue’s technology is developed by its team of leading experts in AI, software verification andsynthesis, and customers include Goldman Sachs and Amazon Web Services.Diffblue is backed by Oxford University, Oxford Sciences Innovation and Goldman Sachs and is headquartered in Oxford, UK. | $6.3M / Series A / Oct 30, 2024 | ||
| Oxford Quantum Circuits developing technology using the power of quantum to do things which have never been achieved before, from enabling life-changing drug discoveries to developing new battery technologies. | $100M / Series B / Nov 27, 2023 | ||
| Caristo Diagnostics is revolutionizing cardiovascular diagnostics and risk prediction with its advanced, AI-based CT imaging analysis tools. | $16.3M / Series A / Apr 17, 2023 | ||
| Diffblue is changing the way software is developed using Artificial Intelligence (AI).Diffblue Cover, the company’s first product, automatically generates tests for Java code to enable development teams to deliver higher quality software, faster. Diffblue’s technology is developed by its team of leading experts in AI, software verification andsynthesis, and customers include Goldman Sachs and Amazon Web Services.Diffblue is backed by Oxford University, Oxford Sciences Innovation and Goldman Sachs and is headquartered in Oxford, UK. | $8M / Series A / Nov 21, 2022 | ||
| Living Optics is commercializing next generation imaging technology which leverages a compact camera system based on breakthroughs in hardware design and software processing. | $22.2M / Series A / Oct 07, 2022 | ||
| Brill Power is a clean-tech platform that develops cutting-edge battery management technology to increase the lifetime performance of lithium-ion battery packs. Founded in 2016, the company is headquartered in Oxford, England. | $10.5M / Series A / Jul 19, 2022 | ||
| Oxford Quantum Circuits developing technology using the power of quantum to do things which have never been achieved before, from enabling life-changing drug discoveries to developing new battery technologies. | $45.4M / Series A / Jul 05, 2022 | ||
| Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany. | $11.5M / Seed / May 12, 2022 | ||
| Founded to commercialise technology developed at Oxford University, Orthox aims to revolutionise the way cartilage injuries are treated. Trauma and erosion of the smooth, stiff cartilage in our joints leads to Osteoarthritis (OA) a debilitating disease, which affects over 300 million patients globally and costs the US economy alone over $128billion each year. Current therapies to repair damaged cartilage focus either on tissue regeneration or on functional replacement; Orthox’s exceptionally strong, resilient, regenerative hydrogel technology, FibroFix™ achieves both these goals, offering a unique solution for the millions of patients suffering from damage to their joints. Initially targeting the knee, Orthox has developed a compelling set of data on lead product FibroFix™ Cartilage which has secured major awards from multiple funding bodies and will shortly enter clinical trials. FibroFix™ technology will then be rolled out to treat other joints and Orthox also has pipeline developments beyond orthopaedics in which strength and tissue regeneration are key. Pipeline expansion is valuable as growth in the annual global biomaterials market will exceed $250 billion by 2025. Orthopaedic biomaterials will form the largest proportion of this and natural biomaterials, like FibroFix™, will be the fastest growing market segment. Orthox: Reducing Pain, Increasing Mobility, Regenerating Strength™. | $12.4M / Series A / Feb 09, 2022 | ||
| See all 29 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Oxford Investment Consultants LLP invest in?
Oxford Investment Consultants LLP invests primarily in Software, Health Care and Biotechnology startups, most often at Series A and Seed stage. Most of the 29 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Oxford Investment Consultants LLP's check size?
Oxford Investment Consultants LLP typically joins rounds of $982k–$12M at Seed and $6.3M–$33M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Oxford Investment Consultants LLP participates in.
How do I contact Oxford Investment Consultants LLP?
Public channels for Oxford Investment Consultants LLP include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Oxford Investment Consultants LLP?
The team at Oxford Investment Consultants LLP includes George Robinson (Founder), Hector Edwards (Investment Associate) and James Mallinson (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
